RE:RE:RE:RE:Timing of trialsI wish you were right but since that article came out after the end of the fiscal year, ,Paul must be referring to the calendar year end when he spoke about being committed to getting those protocols in by the end of the year. If not, he would have said that they successfuly achieved their objective already, right?
palinc2000 wrote: Q-1 has to mean THTX Q-1 Not calendar year Q-1
SPCEO1 wrote: I have an easy fix for that - TH should change its reporting to a calendar year end from November year end. For analysts, it makes life so much easier.
Meanwhile, I think you can assume that he is using normal calendar terminolgy and not fiscal year terminology. But I could be wrong about that as they are not always consistent on that and it has caused me some confusion in the past too.
SABBOBCAT wrote: I think Paul and TH need to be clearer in their communication. Right now it seems they may be mixing terminology that clouds the picture for those of us looking to establish a timeline. In reading the terms "year end" or "in Q1", I would interpret that as fiscal year terminology that refers to November YE and February Q1. On the other hand specifics of before the end of December 2020 or March 2021 should be used if they are referencing the calendar year. If they are using the terms properly and are referring to the fiscal year, they should have filed the INDs and the trials should start before February